Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Negative Symptoms in Early Psychosis
NCT02928965Phase 2Completed
- Sponsor
- The University of Manchester
- Start
- Feb 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia, schizoaffective disorder and schizophreniform disorder comparing Minocycline with Placebo (2 arms). Primary endpoint: Severity of negative symptoms of psychosis at 12 months. Started Feb 2013; status: completed.
02
Drugs
minocycline
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NCT02928965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02928965.